ASD

(Q.1): Which of the following stimulant is shown to have negative net benefit score (benefit minus adverse) in autism spectrum disorder?

(Q.2): Which of the following antipsychotics is shown to have better net benefit score (benefit minus adverse) in patients with autism spectrum disorder (compared to other antipsychotics)?

(Q.3): Which of the following statement is not correct regarding the use of psychotropic medications in patients with autism spectrum disorder (ASD)?

Responses

Your email address will not be published.